TCL Archive Two founding cancer center directors step down: Harold Moses at Vanderbilt-Ingram and Charles Coltman at CTRC. November 19, 2004
TCL Archive Opdivo Study Shows 41 Percent One-Year Survival In Patients With at Least Two Past Therapies November 28, 2014
TCL Archive House-Senate Conferees agree On NCI Total for FY’89, Then Cut It $19 Million August 26, 1988
TCL Archive New NCI division For Center, Training, Organ Systems, Construction Seen As Likely Prospect April 17, 1987
TCL Archive FDA Approves Gilotrif Tablets in NSCLC, Boehringer Ingelheim’s First Approved Cancer Drug July 26, 2013
